Xylo Technologies (XYLO) has a profit margin of -20.19%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2024
Trailing 12 months ending Dec 2024
Xylo Technologies (XYLO) currently reports a profit margin of -20.19% as of December 2024. That compares with -17.49% in the prior-year period — down 15.4% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Xylo Technologies's profit margin history and peer comparisons.
Xylo Technologies's profit margin decreased from -17.49% to -20.19% — a 15.4% year-over-year decrease (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Xylo Technologies's profit margin of -20.19% is lower than the Healthcare sector average of 14.34%. That is roughly 240.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Xylo Technologies's current -20.19% should be judged against Healthcare norms (sector average: 14.34%) and against XYLO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -20.19%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Xylo Technologies, and consider following XYLO for alerts when major investors trade the stock.